Tuesday, November 26, 2024

FDA awards E2E platform testing contract

DFuse Technologies has been awarded a 3-year, $5M contract with the HHS’ Food and Drug Administration (FDA) to provide E2E platform testing. There were 4 other bidders for this task, which was awarded as a small business set-aside action on the CIO-SP3 SB contract vehicle.

Awardee Name: DFUSE TECHNOLOGIES, INC.
Contract Duration: 38 months
Total Contract Value: $4,653,663.92
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 5
RFP ID: C-89488-SB
Award ID: 75F40122F80226
Referenced IDV ID: 75N98120D00208

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required